Blood Community Comments to FDA on Reducing the Risk of Transmission of Hepatitis B Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

America's Blood Centers

Factuality

Ownership

Blood Community Comments to FDA on Reducing the Risk of Transmission of Hepatitis B Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

This joint comment from the Association for the Advancement of Blood and Biotherapies (AABB), America’s Blood Centers (ABC), and the American Red Cross (ARC) to the U.S. Food and Drug Administration (FDA), offers feedback on the draft guidance concerning the mitigation of Hepatitis B Virus (HBV) transmission through human cells, tissues, and cellular and tissue-based products (HCT/Ps). In the submission, the organizations express their support f…